Form 4: MAIA Biotechnology Director Ramiro Guerrero Acquires Shares and Warrants
SEC Form 4 Filing
Director Ramiro Guerrero purchased 6,928 shares of MAIA Biotechnology and warrants to acquire an additional 6,928 shares on March 14, 2024.
Summary
- Ramiro Guerrero, a director of MAIA Biotechnology, acquired 6,928 shares of common stock on March 14, 2024, at a price of $1.17 per share.
- The purchase increased Guerrero's direct holdings to 319,600.04 shares.
- Guerrero also acquired warrants to purchase 6,928 shares of common stock with an exercise price of $1.30.
- The warrants become exercisable six months from the issuance date (March 14, 2024) and expire five years after the initial exercise date.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.
Positives
- A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider trading activity is closely monitored as it can provide insights into a company's prospects, although it's not always indicative of future performance.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Date of the Securities Purchase Agreement. |
| 03/14/2024 | Date of the transaction: purchase of shares and warrants. |
| 09/14/2024 | Warrants become exercisable. |
| 09/14/2029 | Warrants expiration date. |
| 03/15/2024 | Date of signature of the form. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.